Skip to main content
OpenTrials
Completed

NCT Number: NCT05771857

Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19

Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Introduction: COVID 19 pandemic continues to progress with a considerable mortality and morbidity throughout the world since its emergence in December 2019. Many studies were conducted to identify the predictive factors of mortality of those infected with the virus. The previous studies noticed that obesity seems to be associated with severe form of respiratory distress syndrome. Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Methods: investigators led a retrospective monocentric, descriptive and analytic study, in the department of anesthesia and intensive care unit of the university hospital of Mohamed VI Oujda, in Morocco, from March 2020 to October 2021, including all the patients tested positive for the infection.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients presenting an infection with SARS-CoV-2 that were hospitalized in the intensive care unit.

Exclusion criteria

  • None

Treatment and study plan

Obesity

Device

the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19

Primary outcomes

  1. Obesity: An underappreciate risk factor for severe form of COVID-19: Retrospective cohort study of 415 cases

    Time frame: in all the 22 mounths

    Is obesity a predictive factor of need of intensive care, in addition to the mortality of covid 19?

  2. Risk factor for severe form of COVID-19

    Time frame: in all the 22 mounths

    identify the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Sponsors and collaborators

Lead sponsor

Mohammed VI University Hospital

Other

Registry information

Official study title

Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19: Retrospective Cohort Study of 415 Cases

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Mar 16, 2023
Registry last updated
Mar 16, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.